Teva Pharmaceutical Industries Ltd.

Israel

Back to Profile

1-100 of 804 for Teva Pharmaceutical Industries Ltd. and 1 subsidiary Sort by
Query
Excluding Subsidiaries
Aggregations Reset Report
IP Type
        Patent 497
        Trademark 307
Jurisdiction
        World 451
        Europe 151
        United States 111
        Canada 91
Owner / Subsidiary
[Owner] Teva Pharmaceutical Industries Ltd. 804
Teva Pharmaceuticals USA, Inc. 373
Date
New (last 4 weeks) 2
2025 April (MTD) 2
2024 December 5
2025 (YTD) 2
2024 31
See more
IPC Class
A61K 9/20 - Pills, lozenges or tablets 52
A61K 31/135 - Amines, e.g. amantadine having aromatic rings, e.g. methadone 24
A61K 31/47 - QuinolinesIsoquinolines 20
A61K 9/16 - AgglomeratesGranulatesMicrobeadlets 20
A61K 31/4704 - 2-Quinolinones, e.g. carbostyril 16
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 236
35 - Advertising and business services 45
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 36
10 - Medical apparatus and instruments 33
42 - Scientific, technological and industrial services, research and design 29
See more
Status
Pending 42
Registered / In Force 762
  1     2     3     ...     9        Next Page

1.

EMRUSOLMIN FOR USE IN TREATING MULTIPLE SYSTEM ATROPHY

      
Application Number IB2024059428
Publication Number 2025/068949
Status In Force
Filing Date 2024-09-26
Publication Date 2025-04-03
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Giese, Armin
  • Levin, Johannes
  • Izgelov, Dvora
  • Perlstein, Itay
  • Chen, Maria
  • Knebel, Helena
  • Singh, Rajendra Pratap
  • Grossman, Moran
  • Magid, Lital
  • Rubinstein, Efrat
  • Ahn, Andrew
  • Barash, Steve
  • Cicali, Brian
  • Schmidt, Stephan

Abstract

The disclosure provides methods of stabilizing one or more symptoms of Multiple System Atrophy (MSA), limiting the clinical progression of MSA, slowing the clinical progression of MSA, o stabilizing the clinical progression of MSA in a human or population of humans in need thereof, comprising orally administering, on a daily basis, of 300 mg emrusolmin to the human or humans. The disclosure also provide methods of improving overall survival in a human with MSA, improving progress-free survival in a human with MSA, or treating a human having Multiple System Atrophy (MSA) and in need of treatment thereof, comprising orally administering about 300 mg of emrusolmin to the human.

IPC Classes  ?

  • A61K 31/4155 - 1,2-Diazoles not condensed and containing further heterocyclic rings
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

2.

METHODS AND SYSTEMS FOR DETECTING THE PROGRESSION OF A MOVEMENT DISORDER

      
Application Number IL2024050950
Publication Number 2025/069021
Status In Force
Filing Date 2024-09-26
Publication Date 2025-04-03
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Melamed, Michal
  • Rorabaugh, Jacki
  • Reich, Michael
  • Giese, Armin
  • Levin, Johannes
  • Chen, Maria
  • Ahn, Andrew
  • Barash, Steve
  • Knebel, Helena
  • Izgelov, Dvora

Abstract

A method for detecting the progression of multiple system atrophy (MSA) over a time period using a trained machine learning model for a patient with MSA. The method may include receiving in-clinic sensor data and at-home sensor data for a patient over the time period. The method may include determining respective values indicative of a plurality of different MSA-related activity features for the patient based on the in-clinic sensor data and the at-home sensor data. The method may further include determining, using the trained machine learning model, the progression of MSA over the time period for the patient using the respective values for the plurality of different MSA-related activity features for the patient.

IPC Classes  ?

  • A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
  • A61B 5/00 - Measuring for diagnostic purposes Identification of persons

3.

teva

      
Application Number 1829735
Status Registered
Filing Date 2024-09-10
Registration Date 2024-09-10
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

4.

teva

      
Application Number 1829823
Status Registered
Filing Date 2024-09-08
Registration Date 2024-09-08
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

5.

teva

      
Application Number 1829733
Status Registered
Filing Date 2024-09-10
Registration Date 2024-09-10
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

6.

teva

      
Application Number 1829734
Status Registered
Filing Date 2024-09-10
Registration Date 2024-09-10
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

7.

teva

      
Application Number 1829736
Status Registered
Filing Date 2024-09-10
Registration Date 2024-09-10
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

8.

XOZYRLI

      
Application Number 236153700
Status Pending
Filing Date 2024-11-12
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

9.

AERYLFI

      
Application Number 236154200
Status Pending
Filing Date 2024-11-12
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

10.

HUMANIZING HEALTH AWARDS

      
Serial Number 98842546
Status Pending
Filing Date 2024-11-07
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 35 - Advertising and business services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on the job initiatives to enhance patient and caregiver experience. Providing a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

11.

XOZIRLI

      
Application Number 019091345
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

12.

VEXLAYRI

      
Serial Number 98802329
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

13.

AERYLFI

      
Serial Number 98802102
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

14.

XOZYRLI

      
Application Number 019091206
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

15.

AERYLFI

      
Application Number 019091251
Status Registered
Filing Date 2024-10-15
Registration Date 2025-02-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

16.

XOZURRI

      
Application Number 019091290
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

17.

OMKLYNI

      
Application Number 019091348
Status Registered
Filing Date 2024-10-15
Registration Date 2025-02-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

18.

VEXLAYRI

      
Application Number 019091477
Status Registered
Filing Date 2024-10-15
Registration Date 2025-02-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

19.

XOZIRLI

      
Serial Number 98802316
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

20.

XOZURRI

      
Serial Number 98802321
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

21.

OMKLYNI

      
Serial Number 98802322
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

22.

XOZYRLI

      
Serial Number 98802107
Status Pending
Filing Date 2024-10-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

23.

We are all in for better health

      
Application Number 235302200
Status Pending
Filing Date 2024-10-01
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Human pharmaceutical preparations. (1) Research services in the field of human pharmaceuticals. (2) Medical services for humans; human healthcare services; consulting services in the field of human pharmaceuticals.

24.

Nous avons tous à coeur d'améliorer la santé

      
Application Number 235302500
Status Pending
Filing Date 2024-10-01
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Human pharmaceutical preparations. (1) Research services in the field of human pharmaceuticals. (2) Medical services for humans; human healthcare services; consulting services in the field of human pharmaceuticals.

25.

TEVA

      
Application Number 237094700
Status Pending
Filing Date 2024-09-10
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations.

26.

TEVA

      
Application Number 237094600
Status Pending
Filing Date 2024-09-10
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations.

27.

MOVEMENT DISORDER DETECTION AND ASSESSMENT

      
Application Number IL2024050156
Publication Number 2024/166115
Status In Force
Filing Date 2024-02-09
Publication Date 2024-08-15
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Reich, Michael
  • Gotler, Alex
  • Efrati, Itamar

Abstract

The present disclosure relates to systems and methods for assessing severity of involuntary movement associated with tardive dyskinesia (TD). The method includes receiving video data of the patient. The video data may include facial movements of the patient. The method includes processing the video data to identify facial landmark data of the patient, which may include applying an image processing technique to the video data to identify facial landmarks on one or more frames of the video data to produce labeled frames. The method may include applying a plurality of trained machine learning models to the facial landmark data to determine one or more movement severity scores based on changes in the facial landmark data of the patient, where each movement severity score is representative of a category of facial movement, and a total severity score may be generated based on multiple movement severity scores.

IPC Classes  ?

  • A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
  • A61B 5/00 - Measuring for diagnostic purposes Identification of persons

28.

EMPTYING MONITORING SYSTEM FOR GASTROINTESTINAL TRACT DEVICES

      
Application Number IB2023063144
Publication Number 2024/134599
Status In Force
Filing Date 2023-12-21
Publication Date 2024-06-27
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Llan

Abstract

Disclosed herein are apparatus, system, and method aspects for monitoring emptying of a retentive device from a predetermined location of a gastrointestinal tract. An aspect includes an expandable platform (100) used to dispense a medication at the predetermined location of the gastrointestinal tract that includes an emptying monitoring indicator that provides information on emptying of the expandable platform from the predetermined location. The expandable platform may include at least two articulating arms (102-n), a first and a second coupling head (104), a deformable member (106), and a locking assembly (212) that together allow the expandable platform to exist among various configurations. Additional aspects include a receiver (502) and/or a mobile device (504) for receiving a signal from the sensor and providing patient instructions accordingly.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body

29.

TEVA

      
Serial Number 98581718
Status Pending
Filing Date 2024-06-03
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

Training services for pharmacists in the field of pharmacy; educational services, namely conducting online classes and seminars for pharmacists in the field of neurology, cancer, respiratory diseases and women's health.

30.

RETENTIVE DEVICES FOR GASTROINTESTINAL TRACT

      
Application Number 18548915
Status Pending
Filing Date 2022-03-02
First Publication Date 2024-05-02
Owner Teva Pharmaceutical Industries Ltd. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

A device for temporary residence at a predetermined location of the gastrointestinal tract of a subject is described. The device transfers from a closed configuration into an expanded configuration. The device is retained at the predetermined location and transfers from the expanded configuration into an emptying configuration in which the device moves past the predetermined location. The device enables localized medical methods in the gastrointestinal tract of the subject.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body

31.

TEVA

      
Serial Number 98437912
Status Pending
Filing Date 2024-03-07
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for therapeutic use sold empty; medical syringe adapters and replacement parts and accessories therefor; medical fluid injectors

32.

TEVA

      
Serial Number 98437909
Status Pending
Filing Date 2024-03-07
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

Medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for therapeutic use sold empty; medical syringe adapters and replacement parts and accessories therefor; medical fluid injectors

33.

TEVA

      
Serial Number 98437258
Status Pending
Filing Date 2024-03-06
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

Educational services, namely, conducting classes and seminars in the field of neurology, cancer, respiratory diseases and women's health

34.

Humanizing Health Awards

      
Application Number 018938811
Status Registered
Filing Date 2023-10-18
Registration Date 2024-04-16
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on-the-job initiatives to enhance patient and caregiver experience. Organisation of competitions and awards, namely, providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. Hosting a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

35.

HUMANISING HEALTH AWARDS

      
Application Number 018937182
Status Registered
Filing Date 2023-10-13
Registration Date 2024-04-16
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on-the-job initiatives to enhance patient and caregiver experience. Organisation of competitions and awards, namely, providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. Hosting a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

36.

HUMANIZING HEALTH AWARDS

      
Application Number 018937227
Status Registered
Filing Date 2023-10-13
Registration Date 2024-04-16
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on-the-job initiatives to enhance patient and caregiver experience. Organisation of competitions and awards, namely, providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. Hosting a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

37.

TEVA WE ARE ALL IN FOR BETTER HEALTH

      
Application Number 018920168
Status Registered
Filing Date 2023-08-31
Registration Date 2024-01-24
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Human pharmaceutical preparations. Research services in the field of human pharmaceuticals.

38.

DEVICES AND METHODS FOR GASTRIC RETENTIVE DRUG DELIVERY

      
Application Number 18023706
Status Pending
Filing Date 2021-08-27
First Publication Date 2023-08-31
Owner Teva Pharmaceutical Industries Ltd. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device for temporary residence in a stomach of a subject, the device carrying a load of an active pharmaceutical ingredient and having an expanded configuration. When the device is positioned in the stomach and in the expanded configuration, the device is configured to be retained in the stomach of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the pyloric valve. This enables dispensing locally therapeutic substances at a gastric region of a human body.

IPC Classes  ?

  • A61F 5/00 - Orthopaedic methods or devices for non-surgical treatment of bones or jointsNursing devices

39.

DEVICES FOR REGIO-SPECIFIC RELEASE OF CARRIED DRUG AT ILEOCECAL REGION

      
Application Number 18023700
Status Pending
Filing Date 2021-08-27
First Publication Date 2023-08-31
Owner Teva Pharmaceutical Industries Ltd. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device (100) for temporary residence at an ileocecal valve of a subject, the device carrying a load of an active pharmaceutical ingredient (API) and having an expanded configuration. When the device is positioned at the ileocecal valve and in the expanded configuration, the device is configured to be retained at the ileocecal valve of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. This enables dispensing locally therapeutic substances at an ileocecal valve (ICV) region of a human body.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body

40.

HUMANIZING HEALTH CARE

      
Application Number 227161400
Status Pending
Filing Date 2023-07-26
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ?
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on the job initiatives to enhance patient and caregiver experience. (2) Providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. (3) Providing a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

41.

CENMIRA

      
Serial Number 98079248
Status Pending
Filing Date 2023-07-11
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

42.

TEVA

      
Serial Number 98042081
Status Pending
Filing Date 2023-06-14
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract disorders, gastrointestinal and dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, cancer, central nervous system diseases, circulatory system diseases, sensory organ diseases, urogenital organ diseases, peripheral nervous system diseases, bone disorders and bone diseases; Human Pharmaceutical preparations, namely, injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparations

43.

TEVA API

      
Serial Number 98042078
Status Pending
Filing Date 2023-06-14
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 35 - Advertising and business services

Goods & Services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals Business management and business management consulting; public relations; business marketing consulting services; promotion services, namely, promoting the goods and services of others through dissemination of advertising materials on the Internet; business research services; providing business information to others in the field of pharmaceuticals

44.

Miscellaneous Design

      
Serial Number 97927022
Status Pending
Filing Date 2023-05-09
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 41 - Education, entertainment, sporting and cultural services

Goods & Services

Training services for pharmacists in the field of pharmacy; Educational services, namely, conducting online classes and seminars for pharmacists in the fields of neurology, cancer, respiratory diseases and women's health

45.

TEVA

      
Serial Number 97659009
Status Pending
Filing Date 2022-11-02
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 09 - Scientific and electric apparatus and instruments

Goods & Services

Downloadable software in the nature of a mobile application for providing an on-line database to provide patient health improvement in the field of pharmaceuticals, for pharmaceutical interaction analysis, and for treatment of adverse pharmaceutical interactions; Downloadable computer application software for mobile phones, namely, software for keeping track of pharmaceutical dosage schedules and injections; Downloadable computer software for tracking respiratory events and actions, controlling and managing patient medical information, identifying problems concerning adverse drug reactions, and enabling medical clinicians to monitor and manage drug related patient health data

46.

DEVICES AND METHODS FOR REGIO-SPECIFIC DRUG RELEASE AT ILEOCECAL REGION

      
Application Number 17638664
Status Pending
Filing Date 2020-08-30
First Publication Date 2022-10-20
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device for temporary residence at an ileocecal valve of a subject, the device having a trapping configuration, wherein in the trapping configuration, the device is configured to be retained at the ileocecal valve of the subject when the device is positioned at the ileocecal valve; comprises a trapping assembly configured for blocking a cooperating ingestible object while allowing chyme flow, when the device is positioned at the ileocecal valve; and the device being further configured to transfer from the trapping configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. The present disclosure further provides with oral dosage forms cooperating with the device for local dispensing of a therapeutic agent at the ileocecal valve region.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body

47.

RETENTIVE DEVICES FOR GASTROINTESTINAL TRACT

      
Application Number IB2022051815
Publication Number 2022/185220
Status In Force
Filing Date 2022-03-02
Publication Date 2022-09-09
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device (1000) for temporary residence at a predetermined location of the gastrointestinal tract of a subject, the device being configured to transfer from a closed configuration into an expanded configuration. The device is configured to be retained at said predetermined location of the subject. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to move past the predetermined location. This enables localized medical methods in the gastrointestinal tract of the subject.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61B 5/00 - Measuring for diagnostic purposes Identification of persons

48.

FIXED-DOSE PHARMACEUTICAL COMPOSITIONS

      
Document Number 03210689
Status Pending
Filing Date 2022-02-23
Open to Public Date 2022-09-01
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD (Israel)
Inventor
  • Theurer, Marc
  • Steigerwald, Mario

Abstract

The invention relates to fixed-dose pharmaceutical compositions comprising: from 1 to 25 mg rivaroxaban or apixaban; amlodipine, torasemide, bisoprolol or metoprolol; and a pharmaceutically acceptable excipient. The invention also relates to their use in the treatment or prevention of stroke and systemic embolism, and the treatment and prevention of stroke and systemic embolism in patients with essential hypertension.

IPC Classes  ?

  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 9/24 - Layered or laminated unitary dosage forms
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
  • A61K 31/4422 - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine
  • A61K 31/4545 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
  • A61K 31/5377 - 1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
  • A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
  • A61P 9/06 - Antiarrhythmics
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
  • A61P 9/12 - Antihypertensives

49.

FIXED-DOSE PHARMACEUTICAL COMPOSITIONS

      
Application Number IB2022051582
Publication Number 2022/180531
Status In Force
Filing Date 2022-02-23
Publication Date 2022-09-01
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD (Israel)
Inventor
  • Theurer, Marc
  • Steigerwald, Mario

Abstract

The invention relates to fixed-dose pharmaceutical compositions comprising: • from 1 to 25 mg rivaroxaban or apixaban; • amlodipine, torasemide, bisoprolol or metoprolol; and • a pharmaceutically acceptable excipient. The invention also relates to their use in the treatment or prevention of stroke and systemic embolism, and the treatment and prevention of stroke and systemic embolism in patients with essential hypertension.

IPC Classes  ?

  • A61K 9/20 - Pills, lozenges or tablets
  • A61K 9/24 - Layered or laminated unitary dosage forms
  • A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
  • A61K 31/138 - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
  • A61K 31/4422 - 1,4-Dihydropyridines, e.g. nifedipine, nicardipine
  • A61K 31/4545 - Non-condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
  • A61K 31/5377 - 1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
  • A61K 31/64 - Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
  • A61P 9/06 - Antiarrhythmics
  • A61P 9/10 - Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
  • A61P 9/12 - Antihypertensives

50.

DEVICES FOR REGIO-SPECIFIC RELEASE OF CARRIED DRUG AT ILEOCECAL REGION

      
Application Number IB2021057884
Publication Number 2022/043948
Status In Force
Filing Date 2021-08-27
Publication Date 2022-03-03
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device (100) for temporary residence at an ileocecal valve of a subject, the device carrying a load of an active pharmaceutical ingredient (API) and having an expanded configuration. When the device is positioned at the ileocecal valve and in the expanded configuration, the device is configured to be retained at the ileocecal valve of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. This enables dispensing locally therapeutic substances at an ileocecal valve (ICV) region of a human body.

IPC Classes  ?

  • A61M 31/00 - Devices for introducing or retaining media, e.g. remedies, in cavities of the body

51.

DEVICES AND METHODS FOR GASTRIC RETENTIVE DRUG DELIVERY

      
Application Number IB2021057886
Publication Number 2022/043950
Status In Force
Filing Date 2021-08-27
Publication Date 2022-03-03
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device for temporary residence in a stomach of a subject, the device carrying a load of an active pharmaceutical ingredient and having an expanded configuration. When the device is positioned in the stomach and in the expanded configuration, the device is configured to be retained in the stomach of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the pyloric valve. This enables dispensing locally therapeutic substances at a gastric region of a human body.

IPC Classes  ?

  • A61F 5/00 - Orthopaedic methods or devices for non-surgical treatment of bones or jointsNursing devices

52.

TEVACANN

      
Application Number 018652399
Status Registered
Filing Date 2022-02-10
Registration Date 2022-06-15
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Oils containing cannabis (for cosmetic purposes). Cannabis based preparations for human use/ products containing cannabis for human use. Providing medical information relating to products containing cannabis.

53.

TEVACANN

      
Application Number 216499300
Status Pending
Filing Date 2022-02-08
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 34 - Tobacco; smokers' articles
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Oils containing cannabis (for cosmetic purposes). (2) Cannabis based preparations for human use/products containing cannabis for human use. (1) Providing medical information relating to products containing cannabis.

54.

TEVACANN

      
Serial Number 97253500
Status Pending
Filing Date 2022-02-04
Owner Teva Pharmaceutical Industries LTD (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Dietary supplements; vaporizers for medical purposes sold filled with hemp, excluding essential oils, for human use; all of the foregoing goods containing hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD Providing medical information relating to products containing cannabis

55.

JUVIAND

      
Application Number 018634885
Status Registered
Filing Date 2022-01-10
Registration Date 2022-05-11
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparation for treatment of oculars disease and disorders.

56.

ATTENUKINE

      
Serial Number 97205484
Status Pending
Filing Date 2022-01-06
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases

57.

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

      
Application Number 17399753
Status Pending
Filing Date 2021-08-11
First Publication Date 2021-12-16
Owner Teva Pharmaceutical Industries, Ltd. (Israel)
Inventor
  • Blaugrund, Eran
  • Levy, Ruth

Abstract

Disclosed are methods for the treatment of Restless Legs Syndrome comprising administering an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof.

IPC Classes  ?

  • A61K 31/135 - Amines, e.g. amantadine having aromatic rings, e.g. methadone
  • A61K 31/16 - Amides, e.g. hydroxamic acids
  • A61K 31/428 - Thiazoles condensed with carbocyclic rings

58.

Injector pen

      
Application Number 29660932
Grant Number D0936824
Status In Force
Filing Date 2018-08-23
First Publication Date 2021-11-23
Grant Date 2021-11-23
Owner Teva Pharmaceutical Industries Ltd. (Israel)
Inventor Donnelly, Mathew

59.

Miscellaneous Design

      
Application Number 018606310
Status Registered
Filing Date 2021-11-22
Registration Date 2022-04-12
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for human use.

60.

TRUXIMA DESIGN

      
Application Number 214864300
Status Pending
Filing Date 2021-11-19
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Human preparations.

61.

ONGAVIA

      
Application Number 213132700
Status Pending
Filing Date 2021-09-02
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

62.

ONGAVIA

      
Application Number 018546382
Status Registered
Filing Date 2021-09-01
Registration Date 2021-12-29
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparation for treatment of oculars disease and disorders.

63.

LUCIAD

      
Application Number 212197800
Status Pending
Filing Date 2021-07-21
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

64.

ACIMAB

      
Application Number 212198300
Status Registered
Filing Date 2021-07-21
Registration Date 2025-03-26
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

65.

MODYVANZ

      
Application Number 212197600
Status Registered
Filing Date 2021-07-21
Registration Date 2025-03-26
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

66.

MAPTEV

      
Application Number 212197900
Status Registered
Filing Date 2021-07-21
Registration Date 2025-03-26
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

67.

EOSYNQ

      
Serial Number 90817355
Status Pending
Filing Date 2021-07-08
Owner TEVA Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of inflammatory disorders

68.

MODYVANZ

      
Application Number 018493951
Status Registered
Filing Date 2021-06-16
Registration Date 2021-10-16
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparation for treatment of oculars disease and disorders.

69.

MAPTEV

      
Application Number 018494807
Status Registered
Filing Date 2021-06-16
Registration Date 2021-10-16
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparation for treatment of oculars disease and disorders.

70.

TEVA

      
Serial Number 90615726
Status Registered
Filing Date 2021-03-31
Registration Date 2022-04-19
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

Management services of business affairs and commercial functions of an industrial or commercial enterprise, namely, personnel recruitment, personnel management consultancy and accounting services; Business and marketing research, all in the field of pharmaceuticals

71.

TEVA

      
Serial Number 90615708
Status Registered
Filing Date 2021-03-31
Registration Date 2022-04-19
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 35 - Advertising and business services

Goods & Services

Management services of business affairs and commercial functions of an industrial or commercial enterprise, namely, personnel recruitment, personnel management consultancy and accounting services; Business and marketing research, all in the field of pharmaceuticals

72.

DEVICES AND METHODS FOR REGIO-SPECIFIC DRUG RELEASE AT ILEOCECAL REGION

      
Application Number IL2020050941
Publication Number 2021/038572
Status In Force
Filing Date 2020-08-30
Publication Date 2021-03-04
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abstract

The present disclosure provides with a device for temporary residence at an ileocecal valve of a subject, the device having a trapping configuration, wherein in the trapping configuration, the device is configured to be retained at the ileocecal valve of the subject when the device is positioned at the ileocecal valve; comprises a trapping assembly configured for blocking a cooperating ingestible object while allowing chyme flow, when the device is positioned at the ileocecal valve; and the device being further configured to transfer from the trapping configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. The present disclosure further provides with oral dosage forms cooperating with the device for local dispensing of a therapeutic agent at the ileocecal valve region.

IPC Classes  ?

  • A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin

73.

TEVA

      
Serial Number 90266118
Status Registered
Filing Date 2020-10-20
Registration Date 2023-12-19
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

74.

FACE AU QUOTIDIEN

      
Application Number 204494600
Status Registered
Filing Date 2020-08-11
Registration Date 2025-01-03
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Providing information and advice about diseases and disorders for patients and patient caregivers, namely, providing information and advice on the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract diseases and disorders, gastrointestinal diseases and disorders, dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, loss of bone strength and bone health, bone disorders and bone disease, cancer, central nervous system diseases and disorders, circulatory systems diseases and disorders, diseases and disorders of the sensory organs, diseases and disorders of the urogenital organs, neurological disorders, and providing information and advice on the use of injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparations.

75.

TEVAPHARM

      
Application Number 018285645
Status Registered
Filing Date 2020-08-06
Registration Date 2021-01-09
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Pharmaceutical preparations; medicines; dietetic substances adapted for medical use; dietetic foods adapted for medical purposes; nutritional additives for medical purposes; vitamin preparations; preparations of trace elements for human and animal use; mineral food supplements; bacterial preparations for medical use. Consulting services in the field of pharmaceuticals.

76.

S1P3 antagonists

      
Application Number 16751472
Grant Number 11472772
Status In Force
Filing Date 2020-01-24
First Publication Date 2020-05-21
Grant Date 2022-10-18
Owner TEVA PHARMACEUTICAL INDUSTRIES LIMITED (Israel)
Inventor
  • Caramelli, Chiara
  • Federico, Cesare
  • Gabellieri, Emanuele
  • Magnani, Matteo
  • Micco, Iolanda
  • Terstappen, Georg C.

Abstract

The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.

IPC Classes  ?

  • C07D 213/75 - Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
  • C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 413/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 417/12 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
  • C07D 241/16 - Halogen atomsNitro radicals
  • C07D 277/32 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D 401/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
  • C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
  • C07D 417/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings

77.

TEVA

      
Serial Number 88831374
Status Registered
Filing Date 2020-03-12
Registration Date 2020-12-29
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Research services in the field of pharmaceuticals

78.

MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE

      
Application Number IB2019057537
Publication Number 2020/049521
Status In Force
Filing Date 2019-09-06
Publication Date 2020-03-12
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Sundaramurthi, Prakash
  • Mijakovac, Ivana
  • Rasic, Andrea
  • Tunjic, Iva

Abstract

The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 260 mg/ml to 440 mg/ml medroxyprogesterone acetate, about 0.6 mg/ml to 1.5 mg/ml docusate sodium and, polyethylene glycol. Methods of using these compositions are also described.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/00 - Medicinal preparations containing organic active ingredients
  • A61K 47/02 - Inorganic compounds
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

79.

TEVA

      
Serial Number 88829683
Status Registered
Filing Date 2020-03-11
Registration Date 2021-03-30
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals

80.

COPAXONE PEN

      
Application Number 018188354
Status Registered
Filing Date 2020-01-27
Registration Date 2020-05-22
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments

Goods & Services

Pharmaceutical preparations for the treatment of multiple sclerosis. Injection devices sold empty for use in the treatment of multiple sclerosis.

81.

IBREATHE

      
Serial Number 88773994
Status Pending
Filing Date 2020-01-27
Owner Teva Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of respiratory diseases

82.

TEVA

      
Serial Number 88749354
Status Registered
Filing Date 2020-01-07
Registration Date 2021-05-04
Owner Teva Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals

83.

TEVA

      
Serial Number 88749356
Status Registered
Filing Date 2020-01-07
Registration Date 2020-12-22
Owner Teva Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Research services in the field of pharmaceuticals

84.

TEVA API

      
Application Number 199899600
Status Pending
Filing Date 2019-12-03
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 35 - Advertising and business services

Goods & Services

(1) Bulk pharmaceutical chemicals and fine chemicals, namely, active chemical ingredients for use in the manufacture of pharmaceuticals; chemical additives and chemical preparations for use in the manufacture of pharmaceuticals. (1) Business management and business management consulting; public relations; business marketing consulting; promotional services, namely, promoting the goods and services of others through dissemination of advertising for others via the Internet; business research services; providing business information for developing marketing strategies for others in the field of pharmaceuticals.

85.

TEVA

      
Serial Number 88663880
Status Registered
Filing Date 2019-10-22
Registration Date 2020-09-22
Owner Teva Pharmaceutical Industries Limited (Israel)
NICE Classes  ? 36 - Financial, insurance and real estate services

Goods & Services

Providing insurance information regarding access to enrollment and reimbursement programs for the purchase of medications; Providing information to patients about patient insurance reimbursement and insurance coverage for medications; Prescription drug insurance claims assistance services, namely, providing insurance information on patient reimbursement programs; Providing information regarding medical insurance benefits; Providing information on government and other third parties' financial assistance programs to assist in the purchase of medications

86.

teva api

      
Application Number 018129964
Status Registered
Filing Date 2019-09-27
Registration Date 2020-01-25
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 35 - Advertising and business services

Goods & Services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemical and chemical preparations for use in the manufacture of pharmaceuticals. Business management and business management consulting; public relations; business marketing consulting; promotion services, namely, promoting the goods and services of others through dissemination of advertising materials on the Internet; business research services; providing business information to others in the field of pharmaceuticals.

87.

TEVA

      
Application Number 198047000
Status Registered
Filing Date 2019-08-14
Registration Date 2024-09-09
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

88.

TEVA

      
Application Number 198047100
Status Registered
Filing Date 2019-08-14
Registration Date 2024-09-09
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

89.

TEVA

      
Application Number 198047200
Status Registered
Filing Date 2019-08-14
Registration Date 2024-09-09
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

90.

TEVA

      
Application Number 198047300
Status Registered
Filing Date 2019-08-14
Registration Date 2024-09-09
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

91.

teva

      
Application Number 018106028
Status Registered
Filing Date 2019-08-09
Registration Date 2019-12-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

92.

teva

      
Application Number 018106031
Status Registered
Filing Date 2019-08-09
Registration Date 2019-12-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

93.

teva

      
Application Number 018106023
Status Registered
Filing Date 2019-08-09
Registration Date 2019-12-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

94.

teva

      
Application Number 018106024
Status Registered
Filing Date 2019-08-09
Registration Date 2019-12-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

95.

teva

      
Application Number 018106027
Status Registered
Filing Date 2019-08-09
Registration Date 2019-12-14
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations.

96.

teva

      
Application Number 018060410
Status Registered
Filing Date 2019-05-03
Registration Date 2019-10-18
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Pharmaceutical preparations, medicines, dietetic substances adapted for medical use, dietetic foods adapted for medical purposes, nutritional additives for medical purposes, vitamin preparations, preparations of trace elements, mineral food supplements, bacterial preparations for medical use. Surgical, medical, dental and veterinary apparatus and instruments. Consulting services in the field of pharmaceuticals.

97.

Miscellaneous Design

      
Application Number 018060411
Status Registered
Filing Date 2019-05-03
Registration Date 2019-09-17
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 10 - Medical apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Pharmaceutical preparations, medicines, dietetic substances adapted for medical use, dietetic foods adapted for medical purposes, nutritional additives for medical purposes, vitamin preparations, preparations of trace elements, mineral food supplements, bacterial preparations for medical use. Surgical, medical, dental and veterinary apparatus and instruments. Consulting services in the field of pharmaceuticals.

98.

NEW SALT AND SOLID STATE FORMS OF ESCITALOPRAM

      
Application Number IB2018057824
Publication Number 2019/073388
Status In Force
Filing Date 2018-10-09
Publication Date 2019-04-18
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Frenkel, Anton
  • Wu, Raeann Ruiyun

Abstract

The present disclosure relates to a new salt of escitalopram and its solid state forms, processes for the preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

IPC Classes  ?

  • C07D 307/87 - Benzo [c] furansHydrogenated benzo [c] furans
  • A61K 31/343 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
  • A61P 25/24 - Antidepressants

99.

FIZARA

      
Application Number 018040774
Status Registered
Filing Date 2019-03-26
Registration Date 2019-07-09
Owner Teva Pharmaceutical Industries Ltd. (Israel)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of Multiple Sclerosis.

100.

MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE

      
Application Number IB2017055404
Publication Number 2019/048906
Status In Force
Filing Date 2017-09-07
Publication Date 2019-03-14
Owner TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israel)
Inventor
  • Sundaramurthi, Prakash
  • Mijakovac, Ivana

Abstract

The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 360 mg/ml to 440 mg/ml or about 160 mg/ml to 240 mg/ml medroxyprogesterone acetate, 1.7 mg/ml to 2.3 mg/ml docusate sodium, polyethylene glycol, and water. Methods of using these compositions are also described.

IPC Classes  ?

  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/10 - AlcoholsPhenolsSalts thereof, e.g. glycerolPolyethylene glycols [PEG]PoloxamersPEG/POE alkyl ethers
  • A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
  • A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
  • A61K 9/10 - DispersionsEmulsions
  • A61K 31/57 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
  1     2     3     ...     9        Next Page